RESEARCH & DEVELOPMENT

We’ve invested our research dollars in neurology and oncology Research & Development (R&D) for decades in our quest to tackle some of the hardest-to-treat neurological conditions and cancers. We take a disciplined, human biology-based approach to research and develop preventative and curative treatments that will hopefully transform the lives of people impacted by Alzheimers’ and other neurodegenerative diseases, as well as those living with cancer. 

We’re a global R&D organization with two Discovery Centers in the U.S.: 

  • Cambridge, MA draws upon Eisai’s cutting-edge strengths in human genetics, data sciences and precision chemistry to accelerate discovery of breakthrough immunodementia precision therapeutics. 
  •  Exton, PA develops precision oncology therapies by combining biologics expertise, our unique Antibody-Drug Conjugate (ADC) technology, proprietary payloads and bispecific antibodies.  
Follow the science by working across the human biology spectrum to
efficiently deliver breakthrough, disease-modifying therapies.

NEUROLOGY

Eisai's efforts are centered on dementia prevention and delay of progression via next-generation Alzheimer's disease and other neurodegenerative disease compounds now under development. We're also pursuing a new treatment for hypersomnia, as well as expanded indications and new formulations for existing products. Our current neurology R&D initiatives include:
  • Early and Minimally Invasive Diagnostics
  • Novel Neuro-Transmission Pathways 
  • Proteinopathy
  • Neuro Inflammation and Immuno-Genetics 
  • Synapse Micro-Environment
  • Neuronal Regeneration

ONCOLOGY

We are currently exploring more than one dozen molecules, formulations and combinations in clinical trials. Our current oncology R&D initiatives include: 
  • Tumor Micro-Environment  
  • Cell Differentiation and Cancer Stemness 
  • Immunosuppressive Myeloid Lineage and its impact on tumorgenesis 
  • Anti-angiogenesis as an important treatment for cancer  
  • Driver Gene Mutation and Aberrant Splicing in Cancer cells 
The brain is thought of as the last frontier in medical research, and Eisai is at the forefront of creating innovative medications in this area. Everybody has a chance to become a true innovator at Eisai and ultimately work toward helping the growing number of patients suffering from neurodegenerative diseases across the world.
Quotation Mark
Teiji Kimura, Ph.D.
Academia & Industry Alliance Officer
Deep Human Biology Learning Office

WE'RE BETTER TOGETHER

 
See what Eisai can do for your career.

CAREER GROWTH & DEVELOPMENT


We’re dedicated to empowering our employees to grow and excel. This focus on “People Excellence” is central to our human health care mission.
​​​​​​​

COMPENSATION & BENEFITS


​​​​​​​At Eisai, you’ll enjoy a Compensation & Benefits package that features exceptional incentives, benefits, wellness programs and work-life flexibility.
​​​​​​​

LIFE AT EISAI


​​​​​​​
Year-long, we participate in innovation sessions, attend walks with patients and advocacy organizations, celebrate successes, and of course, work together and collaborate.    
Please be advised that the personal information you provide will be used to satisfy your request to receive e-mail alerts from Eisai Inc. ("Eisai" or "we"). Eisai operates this website and our Privacy Policy (https://us.eisai.com/privacy-policywill govern the collection, use, disclosure and retention of the information you provide here. Please do not submit any personal information unless you have read and agree with the terms of that Privacy Policy. Consistent with the Privacy Policy, we and our service providers may use the personal information you provide to contact you and send you communications, including about products, information or services that may interest you. At any time, you may request to be removed from receiving such communications by following the unsubscribe instructions in such e-mails. By clicking "Create Job Alert" above, you agree that you have read, understand, and agree to these conditions.

Lorem Ipsum

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Lorem Ipsum

ONE TEAM

Looking for a team environment where you’ll be challenged to break through and make a real difference?
Join our human health care mission.